Sergiy Denysenko

Alchem Laboratories Corporation

$4,015,653

Attributed

$4,015,653

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $674.1K · FY2015–22

$1M$750K$500K$250K$0

'15

'16

'17

'18

'19

'20

'21

'22

Funding mix

By agency

NIH$4,015,653 · 2

By mechanism

N02$2,720,073 · 2

N01$1,295,580 · 1

Top collaborators

No co-investigators on record.

Most similar at Alchem Laboratories Corporation

Same institution · by research overlap

Emil Pop$2,334,584
Vladimir Rudchenko$3,644,987
James Talton$3,320,110
Mianji Zhang$97,648

Others in their field

Top investigators on “Pharmacologic Substance”

David Heimbrook · Leidos Biomedical Research, Inc.$127,683,054
Myron S Cohen · Family Health International$104,232,876
Wafaa M. El-Sadr · Columbia University Health Sciences$104,068,526
Garret A Fitzgerald · University Of Pennsylvania$73,814,804
James Dennis Neaton · Northwestern University$65,107,995
Sharon L Hillier · Magee-Women'S Hospital Of Upmc$53,206,876

Research focus

Pharmacologic SubstancePreclinical StudyDevelopmental Therapeutics ProgramDrug DiscoveryInvestigational TherapiesMalignant NeoplasmsManufactured SuppliesNational Cancer InstituteNovel TherapeuticsPharmaceutical PreparationsTherapeutic AgentsClinical TrialsResearch PersonnelClinical ResearchProgramsPre-ClinicalPreclinical Trial